REQUEST A DEMO
Total
USD $0.00
Search more companies

Sp Drug Store 2020 Company Limited (Thailand)

Main Activities: Pharmacies and Drug Stores
Full name: Sp Drug Store 2020 Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sp Drug Store 2020 Company Limited is a company based in Thailand, with its head office in Phra Nakhon Si Ayutthaya. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on May 20, 2026. The total number of employees is currently 12 (estimated). There was a net sales revenue increase of 99.85% reported in Sp Drug Store 2020 Company Limited’s latest financial highlights for 2025. Its total assets grew by 49% over the same period. The net profit margin of Sp Drug Store 2020 Company Limited increased by 0.46% in 2025.

Headquarters
36/11 Moo 4
Phra Nakhon Si Ayutthaya; Central Thailand; Postal Code: 13210

Contact Details: Purchase the Sp Drug Store 2020 Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Sp Drug Store 2020 Company Limited report to view the information.
Financial Auditors:
Purchase the Sp Drug Store 2020 Company Limited report to view the information.
Incorporation Date:
May 20, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Sp Drug Store 2020 Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
99.85%
Total Operating Revenue
100.55%
Operating Profit
284.67%
EBITDA
284.67%
Net Profit/Loss for the Period
2811.7%
Total Assets
49%
Total Equity
233.47%
Operating Profit Margin
0.35%
Net Profit Margin
0.46%
Return on Equity (ROE)
61.99%
Debt / Equity
-1224.7%
Quick Ratio
0.01%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?